Xarelto (rivaroxaban) is classified as a specialty drug by many insurance plans and pharmacy benefit managers, even though it doesn’t fit the traditional profile of a specialty medication. It’s an oral tablet stored at room temperature, requires no injections, and needs no special monitoring. Yet its brand-name cost, around $517 per month at list price, pushes it into the specialty tier on many formularies.
Why Insurers Label Xarelto a Specialty Drug
The term “specialty drug” doesn’t have a single, universal definition. Different insurers use different criteria, but the designation generally applies to medications that are high-cost, treat complex conditions, or require special handling like refrigeration or injection. Xarelto checks only one of those boxes: cost. With a wholesale acquisition cost of $517 for a 30-day supply (as of 2023), it crosses the cost threshold that many pharmacy benefit managers use to trigger specialty classification, which is typically somewhere between $600 and $1,000 per month depending on the insurer.
This matters because specialty tier placement often means higher copays, mandatory prior authorization, or a requirement that you fill your prescription through a designated specialty pharmacy rather than your regular retail pharmacy. Some plans also limit fills to 30-day supplies instead of allowing 90-day refills.
How This Affects What You Pay
Your out-of-pocket cost for Xarelto depends heavily on your insurance type and plan design. Medicare Part D enrollees with Xarelto on their formulary pay roughly $89 per month for a 30-day supply, or about $250 for a 90-day supply. For people with commercial insurance, costs vary widely based on tier placement and whether your plan classifies Xarelto as specialty or preferred brand.
A significant price change is coming for Medicare enrollees. Through the Medicare Drug Price Negotiation Program, the negotiated price for Xarelto will drop to $197 per 30-day supply starting in 2026, down from the $517 list price. This should lower out-of-pocket costs for Part D enrollees once the new price takes effect.
For people with commercial insurance, the manufacturer offers the XARELTO withMe Savings Card, which can reduce copays. You’re eligible if you have private or commercial insurance and pay an out-of-pocket cost for the medication. The card is not available to anyone on Medicare, Medicaid, TRICARE, or other government-funded plans.
The SaveOnSP Complication
Some employer-sponsored health plans partner with programs like SaveOnSP that reclassify certain specialty medications, including Xarelto, as “non-essential health benefits.” This is a cost-shifting strategy: by labeling the drug non-essential, the plan removes the Affordable Care Act’s cap on your out-of-pocket spending for that medication. If your plan uses SaveOnSP, you’re also blocked from using the manufacturer’s savings card, which can leave you facing the full specialty-tier copay with no assistance.
If you discover your plan partners with one of these programs, it’s worth asking your HR department or plan administrator about alternative coverage options or exception requests.
How Xarelto Compares to Typical Specialty Drugs
Most drugs that earn the specialty label share characteristics Xarelto lacks. Traditional specialty medications like biologics for rheumatoid arthritis or cancer treatments often require cold-chain shipping, injections or infusions, and ongoing lab monitoring. Xarelto is a once- or twice-daily oral tablet stored at room temperature. The FDA label specifically states that routine blood clotting tests are not recommended to monitor its effect, which makes it simpler to manage than older blood thinners like warfarin that require regular lab visits.
Xarelto is FDA-approved for several conditions, including preventing blood clots after knee or hip replacement surgery, treating deep vein thrombosis and pulmonary embolism, reducing stroke risk in people with atrial fibrillation, and lowering cardiovascular risk in people with coronary or peripheral artery disease. Despite treating serious conditions, none of these uses require the kind of clinical infrastructure that specialty pharmacies were originally designed to provide.
What This Means for Your Prescription
If your plan classifies Xarelto as a specialty drug, you may need to fill it through a specific mail-order or specialty pharmacy rather than picking it up at your local drugstore. You’ll likely face a prior authorization step before your first fill, meaning your doctor will need to submit documentation justifying the prescription. Refills may also be limited to 30-day quantities.
The practical difference between specialty and non-specialty classification comes down to convenience and cost. The medication itself, how you take it, how you store it, is identical regardless of how your insurer categorizes it. The specialty label is a billing and benefits designation, not a clinical one. If you’re switching plans or comparing coverage during open enrollment, checking which tier Xarelto falls on can save you hundreds of dollars over the course of a year.